Gregory Graves, PA
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,674 of the $4,715 with a category attached, or 77.9%. Medtronic accounts for 68.0% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2023 at $2,160 and has fallen 69.7% since, to $655 in 2025.
Across 77 payments — averaging $61.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Boston Scientific$580
- Medical Device Business Services, Inc.$251
- Nevro Corp.$216
- Stryker$182
- Highridge Medical LLC$86
- plus $195 from 7 others
What the payments were for
- Travel & lodging$90519%
- Food & beverage$3,67478%
- Education$1373%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 43 | $3,205 |
| Boston Scientific | 8 | $580 |
| Medical Device Business Services, Inc. | 2 | $251 |
| Nevro Corp. | 6 | $216 |
| Stryker | 8 | $182 |
| Highridge Medical LLC | 1 | $86 |
| Zimmer Biomet | 2 | $43 |
| Pfizer | 2 | $38 |
| Zimvie Inc. | 1 | $29 |
| Davol Inc. | 1 | $27 |
| Solventum Corporation | 1 | $25 |
| Abbott | 1 | $17 |
| Baudax Bio Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,715 in reported general payments places this provider in the 85th percentile of 91 surgical providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 82 | $4,169 |
| Baclofen | 223 | $3,370 |
| Pregabalin | 115 | $2,753 |
| Tizanidine Hcl | 167 | $2,356 |
| Gabapentin | 157 | $1,856 |
| Meloxicam | 563 | $1,536 |
| Methocarbamol | 52 | $590 |
| Duloxetine Hcl | 49 | $571 |
| Oxycodone Hcl | 71 | $392 |
| Cephalexin | 74 | $303 |
| Diclofenac Sodium | 31 | $298 |
| Cyclobenzaprine Hcl | 62 | $298 |
| Methylprednisolone | 48 | $295 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 27 | $253 |
| Nabumetone | 15 | $248 |
Paid to pharmacies, not to this prescriber.
Other surgical in Reno
- Kellie KoppReno$10K
- Curt EricksonReno$7K
- Corinna JewellReno$3K
- Davis AyersReno$3K
- Garret BerkichReno$2K
- Terri ElliottReno$1K
- Kalli MannosReno$1K
- Olivia AndersonReno$1K
- Renee CoveyReno$1K
- Samantha PerkinsReno$880
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.